Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 428

Results For "patient"

4755 News Found

Sanofi invests US $ 180 mn in Owkin’s AI for oncology pipeline
Biotech | November 26, 2021

Sanofi invests US $ 180 mn in Owkin’s AI for oncology pipeline

Owkin builds best-in-class predictive biomedical AI models and robust data sets


GreenLight Biosciences and Samsung Biologics to build vaccine capacity
Biotech | November 25, 2021

GreenLight Biosciences and Samsung Biologics to build vaccine capacity

The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate


ICMR approves Meril’s Rapid Antigen Test kit
Drug Approval | November 25, 2021

ICMR approves Meril’s Rapid Antigen Test kit

The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes


Gastrointestinal disorders increasing in India
Public Health | November 25, 2021

Gastrointestinal disorders increasing in India

It is estimated that one-third of our country’s population has some form of these disorders


Boehringer Ingelheim India enters Guinness World Records through its Stroke campaign
Healthcare | November 25, 2021

Boehringer Ingelheim India enters Guinness World Records through its Stroke campaign

The week-long campaign received a record 17.691 pledges


Medical devices industry needs reforms:  Mehernosh Daruwalla, Founder & MD, Lotus Surgicals
interviews | November 24, 2021

Medical devices industry needs reforms: Mehernosh Daruwalla, Founder & MD, Lotus Surgicals

The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector


Arrowhead Pharmaceuticals enters agreement with GSK to develop NASH drug candidate
Biotech | November 24, 2021

Arrowhead Pharmaceuticals enters agreement with GSK to develop NASH drug candidate

Arrowhead to receive US $ 120 million upfront payment for Phase 1/2 program for NASH and is eligible to receive potential milestone payments and royalties on commercial sales


U.S. FDA approves first treatment for drug-resistant post-transplant infection
Drug Approval | November 24, 2021

U.S. FDA approves first treatment for drug-resistant post-transplant infection

The approval is for Cytomegalovirus, a type of Herpes virus


Vivera announces launch of new testing software, LabPort
Digitisation | November 24, 2021

Vivera announces launch of new testing software, LabPort

Featuring identity verification using artificial intelligence (AI), LabPort was designed to facilitate immediate results reporting for diagnostic testing even in high-volume, field-based testing environments


Fortis Escorts Faridabad introduces Cryo technique to treat lung cancer
Hospitals | November 24, 2021

Fortis Escorts Faridabad introduces Cryo technique to treat lung cancer

Cryo-technology helps in early diagnosis and palliative care in later stages of cancer